Combined Administration of Mesenchymal Stem Cells Overexpressing IGF-1 and HGF Enhances Neovascularization but Moderately Improves Cardiac Regeneration in a Porcine Model

Overview

Journal Stem Cell Res Ther

Publisher Biomed Central

Date 2016 Jul 18

PMID 27423905

Citations 29

Authors

Guadalupe Gomez-Mauricio

Isabel Moscoso

Maria-Fernanda Martin-Cancho

Veronica Crisostomo

Cristina Prat-Vidal

Claudia Baez-Diaz

Francisco M Sanchez-Margallo

Antonio Bernad

Affiliations

Soon will be listed here.

Abstract

Background: Insulin-like growth factor 1 (IGF-1) and hepatocyte growth factor (HGF) are among the most promising growth factors for promoting cardiorepair. Here, we evaluated the combination of cell- and gene-based therapy using mesenchymal stem cells (MSC) genetically modified to overexpress IGF-1 or HGF to treat acute myocardial infarction (AMI) in a porcine model.

Methods: Pig MSC from adipose tissue (paMSC) were genetically modified for evaluation of different therapeutic strategies to improve AMI treatment. Three groups of infarcted Large White pigs were compared (I, control, non-transplanted; II, transplanted with paMSC-GFP (green fluorescent protein); III, transplanted with paMSC-IGF-1/HGF). Cardiac function was evaluated non-invasively using magnetic resonance imaging (MRI) for 1 month. After euthanasia and sampling of the animal, infarcted areas were studied by histology and immunohistochemistry.

Results: Intramyocardial transplant in a porcine infarct model demonstrated the safety of paMSC in short-term treatments. Treatment with paMSC-IGF-1/HGF (1:1) compared with the other groups showed a clear reduction in inflammation in some sections analyzed and promoted angiogenic processes in ischemic tissue. Although cardiac function parameters were not significantly improved, cell retention and IGF-1 overexpression was confirmed within the myocardium.

Conclusions: The simultaneous administration of IGF-1- and HGF-overexpressing paMSC appears not to promote a synergistic effect or effective repair. The combined enhancement of neovascularization and fibrosis in paMSC-IGF-1/HGF-treated animals nonetheless suggests that sustained exposure to high IGF-1 + HGF levels promotes beneficial as well as deleterious effects that do not improve overall cardiac regeneration.

Citing Articles

Genetically modified mesenchymal stromal cells: a cell-based therapy offering more efficient repair after myocardial infarction.

Xu C, Xie Y, Wang B Stem Cell Res Ther. 2024; 15(1):323.

PMID: 39334266 PMC: 11438184. DOI: 10.1186/s13287-024-03942-7.

Priming mesenchymal stem cells to develop "super stem cells".

Haider K World J Stem Cells. 2024; 16(6):623-640.

PMID: 38948094 PMC: 11212549. DOI: 10.4252/wjsc.v16.i6.623.

Emerging Strategies in Mesenchymal Stem Cell-Based Cardiovascular Therapeutics.

Kumar R, Mishra N, Tran T, Kumar M, Vijayaraghavalu S, Gurusamy N Cells. 2024; 13(10.

PMID: 38786076 PMC: 11120430. DOI: 10.3390/cells13100855.

Intracoronary Administration of Microencapsulated HGF in a Reperfused Myocardial Infarction Swine Model.

Blanco-Blazquez V, Baez-Diaz C, Sanchez-Margallo F, Gonzalez-Bueno I, Martin H, Blazquez R J Cardiovasc Dev Dis. 2023; 10(2).

PMID: 36826582 PMC: 9960949. DOI: 10.3390/jcdd10020086.

Transplantation of Skeletal Muscle-Derived Sca-1/PW1/Pax7 Interstitial Cells (PICs) Improves Cardiac Function and Attenuates Remodeling in Mice Subjected to Myocardial Infarction.

Ruchaya P, Lewis-McDougall F, Sornkarn N, Amin S, Grimsdell B, Shaalan A Cells. 2022; 11(24).

PMID: 36552813 PMC: 9776789. DOI: 10.3390/cells11244050.

References

Ellison G, Torella D, Dellegrottaglie S, Perez-Martinez C, de Prado A, Vicinanza C . Endogenous cardiac stem cell activation by insulin-like growth factor-1/hepatocyte growth factor intracoronary injection fosters survival and regeneration of the infarcted pig heart. J Am Coll Cardiol. 2011; 58(9):977-86. DOI: 10.1016/j.jacc.2011.05.013. View

Ishigami S, Ohtsuki S, Tarui S, Ousaka D, Eitoku T, Kondo M . Intracoronary autologous cardiac progenitor cell transfer in patients with hypoplastic left heart syndrome: the TICAP prospective phase 1 controlled trial. Circ Res. 2014; 116(4):653-64. DOI: 10.1161/CIRCRESAHA.116.304671. View

Lu F, Zhao X, Wu J, Cui Y, Mao Y, Chen K . MSCs transfected with hepatocyte growth factor or vascular endothelial growth factor improve cardiac function in the infarcted porcine heart by increasing angiogenesis and reducing fibrosis. Int J Cardiol. 2012; 167(6):2524-32. DOI: 10.1016/j.ijcard.2012.06.052. View

Orlic D, Kajstura J, Chimenti S, Limana F, Jakoniuk I, Quaini F . Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci U S A. 2001; 98(18):10344-9. PMC: 56963. DOI: 10.1073/pnas.181177898. View

Savi M, Bocchi L, Fiumana E, Karam J, Frati C, Bonafe F . Enhanced engraftment and repairing ability of human adipose-derived stem cells, conveyed by pharmacologically active microcarriers continuously releasing HGF and IGF-1, in healing myocardial infarction in rats. J Biomed Mater Res A. 2015; 103(9):3012-25. DOI: 10.1002/jbm.a.35442. View

Koellensperger E, Lampe K, Beierfuss A, Gramley F, Germann G, Leimer U . Intracutaneously injected human adipose tissue-derived stem cells in a mouse model stay at the site of injection. J Plast Reconstr Aesthet Surg. 2014; 67(6):844-50. DOI: 10.1016/j.bjps.2014.02.021. View

Gomez-Mauricio R, Acarregui A, Sanchez-Margallo F, Crisostomo V, Gallo I, Hernandez R . A preliminary approach to the repair of myocardial infarction using adipose tissue-derived stem cells encapsulated in magnetic resonance-labelled alginate microspheres in a porcine model. Eur J Pharm Biopharm. 2012; 84(1):29-39. DOI: 10.1016/j.ejpb.2012.11.028. View

Martin-Rendon E, Brunskill S, Hyde C, Stanworth S, Mathur A, Watt S . Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review. Eur Heart J. 2008; 29(15):1807-18. DOI: 10.1093/eurheartj/ehn220. View

Malliaras K, Ibrahim A, Tseliou E, Liu W, Sun B, Middleton R . Stimulation of endogenous cardioblasts by exogenous cell therapy after myocardial infarction. EMBO Mol Med. 2014; 6(6):760-77. PMC: 4203354. DOI: 10.1002/emmm.201303626. View

10.

Sonnenberg S, Rane A, Liu C, Rao N, Agmon G, Suarez S . Delivery of an engineered HGF fragment in an extracellular matrix-derived hydrogel prevents negative LV remodeling post-myocardial infarction. Biomaterials. 2015; 45:56-63. PMC: 4326250. DOI: 10.1016/j.biomaterials.2014.12.021. View

11.

Kouroupi G, Lavdas A, Gaitanou M, Thomaidou D, Stylianopoulou F, Matsas R . Lentivirus-mediated expression of insulin-like growth factor-I promotes neural stem/precursor cell proliferation and enhances their potential to generate neurons. J Neurochem. 2010; 115(2):460-74. DOI: 10.1111/j.1471-4159.2010.06939.x. View

12.

Maxeiner H, Krehbiehl N, Muller A, Woitasky N, Akinturk H, Muller M . New insights into paracrine mechanisms of human cardiac progenitor cells. Eur J Heart Fail. 2010; 12(7):730-7. DOI: 10.1093/eurjhf/hfq063. View

13.

Chen Q, Fischer A, Reagan J, Yan L, Ames B . Oxidative DNA damage and senescence of human diploid fibroblast cells. Proc Natl Acad Sci U S A. 1995; 92(10):4337-41. PMC: 41939. DOI: 10.1073/pnas.92.10.4337. View

14.

Mohsin S, Siddiqi S, Collins B, Sussman M . Empowering adult stem cells for myocardial regeneration. Circ Res. 2011; 109(12):1415-28. PMC: 3266718. DOI: 10.1161/CIRCRESAHA.111.243071. View

15.

da Silva Meirelles L, Nardi N . Murine marrow-derived mesenchymal stem cell: isolation, in vitro expansion, and characterization. Br J Haematol. 2003; 123(4):702-11. DOI: 10.1046/j.1365-2141.2003.04669.x. View

16.

Jansen of Lorkeers S, Eding J, Vesterinen H, van der Spoel T, Sena E, Duckers H . Similar effect of autologous and allogeneic cell therapy for ischemic heart disease: systematic review and meta-analysis of large animal studies. Circ Res. 2014; 116(1):80-6. DOI: 10.1161/CIRCRESAHA.116.304872. View

17.

Nassiri S, Rahbarghazi R . Interactions of mesenchymal stem cells with endothelial cells. Stem Cells Dev. 2013; 23(4):319-32. DOI: 10.1089/scd.2013.0419. View

18.

Lu-Nguyen N, Broadstock M, Yanez-Munoz R . Efficient Expression of Igf-1 from Lentiviral Vectors Protects In Vitro but Does Not Mediate Behavioral Recovery of a Parkinsonian Lesion in Rats. Hum Gene Ther. 2015; 26(11):719-33. PMC: 4651049. DOI: 10.1089/hum.2015.016. View

19.

Hassan N, Tchao J, Tobita K . Concise review: skeletal muscle stem cells and cardiac lineage: potential for heart repair. Stem Cells Transl Med. 2013; 3(2):183-93. PMC: 3925055. DOI: 10.5966/sctm.2013-0122. View

20.

Yu B, Zhang X, Li X . Exosomes derived from mesenchymal stem cells. Int J Mol Sci. 2014; 15(3):4142-57. PMC: 3975389. DOI: 10.3390/ijms15034142. View